Gene Expression Profiling for Smoldering Myeloma Patients
Gareth Morgan, MD, PhD, the director of the Myeloma Institute at the University of Arkansas, discusses gene expression profiling for patients with smoldering myeloma.
Gareth Morgan, MD, PhD, the director of the Myeloma Institute at the University of Arkansas, discusses gene expression profiling for patients with smoldering myeloma.
Clinical pearls:
- Smoldering myeloma doesn’t act as a single disease.
- Gene expression profiling, a clinical staging system based on four genes, is used as an approach to identify high-risk progression of this disease. It is also used as technique to determine which patients would progress in one year.
- Intervention studies or treatments can be used following gene expression profiling.
Recent Videos
Related Content
Fellow's Perspective: Impact of Quadruplet and MRD in Newly Diagnosed Multiple Myeloma
December 17th 2024Article
In a discussion with Peers & Perspectives in Oncology, fellowship program director Marc J. Braunstein, MD, PhD, FACP, and hematology/oncology fellow Olivia Main, MD, talk about how recent trials shape their approach for a patient with transplant-eligible multiple myeloma.
Read More
